Protalix BioTherapeutics Inc (PLX)
1.205
+0.02
(+2.12%)
USD |
NYAM |
Apr 23, 16:00
1.205
0.00 (0.00%)
After-Hours: 20:00
Protalix BioTherapeutics Total Liabilities (Quarterly): 50.86M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 50.86M |
| September 30, 2023 | 49.32M |
| June 30, 2023 | 49.42M |
| March 31, 2023 | 65.55M |
| December 31, 2022 | 66.43M |
| September 30, 2022 | 68.22M |
| June 30, 2022 | 70.53M |
| March 31, 2022 | 75.88M |
| December 31, 2021 | 79.70M |
| September 30, 2021 | 83.27M |
| June 30, 2021 | 104.36M |
| March 31, 2021 | 88.29M |
| December 31, 2020 | 94.97M |
| September 30, 2020 | 105.62M |
| June 30, 2020 | 106.47M |
| March 31, 2020 | 113.76M |
| December 31, 2019 | 115.71M |
| September 30, 2019 | 124.58M |
| June 30, 2019 | 122.73M |
| March 31, 2019 | 120.90M |
| December 31, 2018 | 114.01M |
| September 30, 2018 | 132.19M |
| June 30, 2018 | 101.29M |
| March 31, 2018 | 104.24M |
| December 31, 2017 | 101.67M |
| Date | Value |
|---|---|
| September 30, 2017 | 87.13M |
| June 30, 2017 | 79.67M |
| March 31, 2017 | 140.32M |
| December 31, 2016 | 92.20M |
| September 30, 2016 | 85.58M |
| June 30, 2016 | 86.84M |
| March 31, 2016 | 84.66M |
| December 31, 2015 | 86.38M |
| September 30, 2015 | 128.00M |
| June 30, 2015 | 131.09M |
| March 31, 2015 | 133.20M |
| December 31, 2014 | 133.96M |
| September 30, 2014 | 132.49M |
| June 30, 2014 | 136.44M |
| March 31, 2014 | 136.99M |
| December 31, 2013 | 140.28M |
| September 30, 2013 | 137.86M |
| June 30, 2013 | 74.29M |
| March 31, 2013 | 76.22M |
| December 31, 2012 | 82.08M |
| September 30, 2012 | 72.61M |
| June 30, 2012 | 76.44M |
| March 31, 2012 | 74.92M |
| December 31, 2011 | 77.88M |
| September 30, 2011 | 78.18M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
49.32M
Minimum
Sep 2023
124.58M
Maximum
Sep 2019
86.09M
Average
83.27M
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
| Agenus Inc | 462.30M |
| InfuSystems Holdings Inc | 50.61M |
| Corbus Pharmaceuticals Holdings Inc | 35.18M |
| AIM ImmunoTech Inc | 9.147M |
| Armata Pharmaceuticals Inc | 130.43M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 84.43M |
| Shareholders Equity (Quarterly) | 33.57M |
| Debt to Equity Ratio | 0.6033 |
| Current Ratio | 1.536 |
| Net Debt Paydown Yield | 1.21% |